Showing results (101-110 of 124) with videos related to
Sort By:
Pageof 13
Molecular Therapy. Nucleic Acids|April 18, 2022
Rescue of mis-splicing of a common <i>SLC26A4</i> mutant associated with sensorineural hearing loss by antisense oligonucleotidesPengchao Feng, Zhijiao Xu, Jialin Chen, et al.American Journal of Human Genetics|September 6, 2024
Hearing restoration by gene replacement therapy for a multisite-expressed gene in a mouse model of human DFNB111 deafnessLuoying Jiang, Shao Wei Hu, Zijing Wang, et al.Human Genetics|November 16, 2022
Hearing of Otof-deficient mice restored by trans-splicing of N- and C-terminal otoferlinHonghai Tang, Hui Wang, Shengyi Wang, et al.Journal of Environmental Quality|October 5, 2020
Global Research Alliance N<sub>2</sub> O chamber methodology guidelines: Guidelines for gap-filling missing measurementsChristopher D Dorich, Daniele De Rosa, Louise Barton, et al.Molecular Therapy. Nucleic Acids|August 29, 2022
Precise detection of CRISPR-Cas9 editing in hair cells in the treatment of autosomal dominant hearing lossChong Cui, Daqi Wang, Bowei Huang, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|September 16, 2005
Studies of "pinwheel-like" bis[1,8,15,22-tetrakis(3-pentyloxy)phthalocyaninato] rare earth(III) double-decker complexesRongming Wang, Renjie Li, Yongzhong Bian, et al.Molecular Therapy. Nucleic Acids|February 26, 2024
Hair cell-specific Myo15 promoter-mediated gene therapy rescues hearing in DFNB9 mouse modelHui Wang, MengZhao Xun, Honghai Tang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2025
Comparative analysis of RNA versus protein splicing in dual AAV-mediated gene therapy in a mouse model of DFNB9 deafnessMengzhao Xun, Xintai Fan, Hui Wang, et al.Clinical Genetics|May 23, 2022
A humanized murine model, demonstrating dominant progressive hearing loss caused by a novel KCNQ4 mutation (p.G228D) from a large Chinese familyChong Cui, Luping Zhang, Fuping Qian, et al.Molecular Therapy. Methods & Clinical Development|November 29, 2023
Preclinical evaluation of the efficacy and safety of AAV1-hOTOF in mice and nonhuman primatesLonglong Zhang, Hui Wang, Mengzhao Xun, et al.Pageof 13